Gliclazid retard Zentiva 60 mg Tabletten - 30 Tablette(n) Swissmedic Key 65362001 Registration Holder Helvepharm AG Name Gliclazid retard Zentiva 60 mg Tabletten Date of registration 03.03.2015 Original/Generic Generic Introduction of Sequence 03.03.2015 ATC-Classification Gliclazide (A10BB09) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.06.20. Show package size 30 Tablette(n) Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 7.55 Limitation Yes Limitation text
Deductible 10 % Consumer price 16.90 Feedback FB Daily cost GTIN 7680653620010 Medication Code Synthetika Pharmacode 6266130 Disponibility
Composition gliclazidum 60 mg, lactosum monohydricum 163.8 mg, hypromellosum, magnesii stearas pro compresso. Packungsbestandteile Active Agent Dose Gliclazide 60 mg
BAG: Active Agent Dose Gliclazide 60 mg
Inactive agents Dose Hypromellosum Lactose Monohydrate 163.8 mg Magnesii Stearas pro Compresso
Source Data was imported : 08.01.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
